Fluxergy is the First Company to Utilize the National Institutes of Health Diagnostics Preclinical Services to Support Molecular Platform Development

Fluxergy announces collaboration with National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) IRVINE, Calif., Nov. 18, 2024 /PRNewswire-PRWeb/ -- FLUXERGY, an Irvine-based medical diagnostic company re-envisioning point-of-care testing with a...